
Sign up to save your podcasts
Or
The doctors are joined by John Huemoeller, CEO of AXIM Biotechnologies, who is a biotech leader on a mission to innovate the eye care industry with a new one-of-a-kind test that helps to diagnose people with Dry Eye Disease.
As we know, Dry Eye Disease has been very difficult to diagnose due to its symptoms and many causes, it is estimated to impact at least 6.8% of the U.S. population. AXIM’s new MMP-9 test, which is the first rapid quantitative tear test for Matrix metalloproteinase-9 (MMP-9), an inflammatory biomarker for Dry Eye Disease, is set to change the future of DED diagnostics.
Tune in to listen to learn about the new technology and find more information about it at AXIMEYE!
5
2727 ratings
The doctors are joined by John Huemoeller, CEO of AXIM Biotechnologies, who is a biotech leader on a mission to innovate the eye care industry with a new one-of-a-kind test that helps to diagnose people with Dry Eye Disease.
As we know, Dry Eye Disease has been very difficult to diagnose due to its symptoms and many causes, it is estimated to impact at least 6.8% of the U.S. population. AXIM’s new MMP-9 test, which is the first rapid quantitative tear test for Matrix metalloproteinase-9 (MMP-9), an inflammatory biomarker for Dry Eye Disease, is set to change the future of DED diagnostics.
Tune in to listen to learn about the new technology and find more information about it at AXIMEYE!
90,382 Listeners
77 Listeners
367,578 Listeners
101 Listeners
47,703 Listeners
29,128 Listeners
4,467 Listeners
1,619 Listeners